Nxera Pharma Co., Ltd. (SOLTF)
5.28
0.00 (0.00%)
USD |
OTCM |
Apr 10, 16:00
Nxera Pharma EPS Diluted (Quarterly) : -0.5538 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.1082 |
| AnGes, Inc. | -0.0072 |
| SanBio Co., Ltd. | -0.095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.11M |
| Revenue (Quarterly) | 50.41M |
| Total Expenses (Quarterly) | 100.53M |
| Enterprise Value | 713.95M |
| Gross Profit Margin (Quarterly) | 73.58% |
| Profit Margin (Quarterly) | -99.41% |
| Earnings Yield | -17.37% |
| Normalized Earnings Yield | -17.37 |